Cargando…
Redox Dual-Responsive and O(2)‑Evolving Theranostic Nanosystem for Highly Selective Chemotherapy against Hypoxic Tumors
Activatable theranostic agents, which combine fluorescent reporters with masked chemotherapeutic agents that are activated by tumor-associated stimuli, would be attractive candidates to improve the tumor selectivity of chemotherapy. This work reports a ROS/GSH dual-activatable and O(2)‑evolving ther...
Autores principales: | Chen, Huachao, Li, Fei, Yao, Yongrong, Wang, Zhe, Zhang, Zhihao, Tan, Ninghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332786/ https://www.ncbi.nlm.nih.gov/pubmed/30662556 http://dx.doi.org/10.7150/thno.30259 |
Ejemplares similares
-
Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
por: Yao, Yongrong, et al.
Publicado: (2022) -
Hyaluronic Acid Coated Liposomes Co-Delivery of Natural Cyclic Peptide RA-XII and Mitochondrial Targeted Photosensitizer for Highly Selective Precise Combined Treatment of Colon Cancer
por: Xu, Yanqing, et al.
Publicado: (2021) -
Sequential Delivery of Cyclopeptide RA-V and Doxorubicin for Combination Therapy on Resistant Tumor and In Situ Monitoring of Cytochrome c Release
por: Chen, Huachao, et al.
Publicado: (2017) -
Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
por: Garello, Francesca, et al.
Publicado: (2018) -
Extracellular Vesicles as Mediators of Cancer Disease and as Nanosystems in Theranostic Applications
por: Burgos-Ravanal, Renato, et al.
Publicado: (2021)